ALL NEW ASD & ADHD REFERRALS ARE CURRENTLY ON HOLD - PLEASE READ MORE HERE.

The ICB has announced an immediate change to the way ASD & ADHD referrals are processed and we are currently unable to submit any new referrals for either adults or children. We do not currently know when we will be able to start accepting new requests again but will update our webpage as soon as referrals can resume so please check back again soon. We apologise for any inconvenience this delay may cause but these changes are outside the control of the practice. Thank you for your understanding.

Read more
icon

Shared Care Agreements

What is a Shared Care Agreement (SCA)?

This is a document detailing an agreement between the practice and a specialist regarding prescription of certain medication. The relevant medicines are only able to be initiated and titrated (dose adjusted) by a specialist as per current prescribing regulations. The document sets out who is responsible for what with regards to undertaking monitoring blood tests or other assessments, the thresholds at which further action should be taken should things progress in an adverse way and who is responsible for actioning these issues. With this in place the practice agree to take over responsibility for issuing repeat prescriptions of these medications. Without one, responsibility for prescriptions remains with the relevant specialist teams. SCAs are created by the specialist team and sent to the practice to agree.

Which medicines require a Shared Care Agreement (SCA)?

There are a category of drugs known as “amber drugs subject to a shared care agreement”. Any drug in this category requires this document in place before GPs can take over prescribing them.

Most commonly these are either medicines which regulate the immune system response, such as Methotrexate and Azathioprine, or are medicines used in the treatment of conditions like ADHD such as Methylphenidate (brand names include Concerta, Medikinet and Equasym).

Do practices have to agree to these when they are received?

No. All shared care agreements (SCAs) are entered into on a voluntary basis by the practice. They are not included in the services required within the contract that practices hold with the NHS. In most cases there is no additional funding available for undertaking the work to provide the agreed monitoring.

My specialist has commenced me on treatment with a drug subject to a Shared Care Agreement (SCA). What now?

Your specialist team can continue issuing prescriptions for you and undertaking the required monitoring. The practice will record on your notes that you are taking this medicine in order to avoid drug interactions with other medicines you are prescribed, but we will not be able to issue prescriptions either routinely or urgently – you will need to contact the specialist team directly for a prescription even if you have run out of medication as the practice are not able to prescribe these drugs without the relevant agreement in place.

SCAs for Gender Dysphoria Patients

As outlined above, Shared Care Agreements may be entered into on a voluntary basis by practices that are willing to take on prescribing responsibility and oversight of patient treatment.  As a practice, our GP partners do not feel it appropriate to agree to shared care for gender dysphoria patients due to a lack of expertise in this area, which is highly specialist and requires off-licence prescribing.  We will therefore not be entering into any agreements for this type of treatment as we feel it is is more appropriate for patients to be monitored and receive prescriptions from the gender clinic specialists.